GSK5764227 (HS-20093) is a novel antibody-drug conjugate composed of a fully human anti-B7-H3 monoclonal antibody covalently linked to a topoisomerase inhibitor payload.

The researchers also projected that newly diagnosed MM cases will increase by 70.8% by 2045 — from about 188,000 cases in 2022 to about 321,000 cases in 2045. The number of deaths due to MM is ...

A study of more than 3000 physician practices revealed an increase in social risk screening from 2017 to 2022.

An expert panel consisting of dietitians, doctors, nutritional epidemiologists, chefs, and weight loss researchers examined the evidence behind 38 diets.

Patient-centered pathology reports help patients understand prostate cancer results better than standard reports.

Erectile dysfunction (ED) and testosterone deficiency (TD) are more common among men with testicular cancer, according to research published in The Journal of Urology.

The 5-year recurrence-free survival rate was 75% in the younger age group and 73% in the older age group.

Researchers found that, in the most recent decade evaluated, the incidence of early-onset colorectal cancer increased in 27 countries and territories.

Biased patient handoffs impede accurate transfer of clinical information among medical trainees, a study suggests.

Alcohol is a well-established, preventable cause of cancer responsible for about 100,000 cases of cancer and 20,000 cancer deaths annually in the United States,” said Surgeon General Vivek Murthy, MD.

The US Food and Drug Administration (FDA) has accepted for priority review the new drug application (NDA) for avutometinib to be used in combination with defactinib for the treatment of adults with ...

A phase 3 trial confirms “the potent anti-leukemic effect” of consolidation with allogeneic transplant in older patients with acute myeloid leukemia, according to researchers.